Clinical Trial Update: Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy of intravitreal Triamcinolone and Bevacizumab for diabetic macular edema; study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Rubens Belfort Jr. | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED